Illumina, Inc. (ILMN)

Basic

  • Market Cap

    $16.19B

  • EV

    $17.53B

  • Shares Out

    158.8M

  • Revenue

    $4,465M

  • Employees

    11,530

Margins

  • Gross

    65.78%

  • EBITDA

    7.1%

  • Operating

    -2.51%

  • Pre-Tax

    -25.04%

  • Net

    -25.2%

  • FCF

    3.78%

Returns (5Yr Avg)

  • ROA

    5.38%

  • ROE

    4.15%

  • ROCE

    10.35%

  • ROIC

    13.39%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $153.35

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $28.3

  • Earnings (Dil)

    -$7.13

  • FCF

    $1.07

  • Book Value

    $37.33

Growth (CAGR)

  • Rev 3Yr

    11.31%

  • Rev 5Yr

    6.6%

  • Rev 10Yr

    12.76%

  • Dil EPS 3Yr

    18.24%

  • Dil EPS 5Yr

    9.07%

  • Dil EPS 10Yr

    23.87%

  • Rev Fwd 2Yr

    1.41%

  • EBITDA Fwd 2Yr

    -12.65%

  • EPS Fwd 2Yr

    -26.61%

  • EPS LT Growth Est

    -32.22%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '13
Jan '16
Dec '17
Dec '19
Jan '22
LTM

Total Revenues

3,333.0

3,543.0

3,239.0

4,526.0

4,584.0

4,465.0

Total Revenues % Chg.

21.1%

6.3%

-8.6%

39.7%

1.3%

-5.0%

Cost of Goods Sold, Total

998.0

1,042.0

1,008.0

1,301.0

1,439.0

1,528.0

Gross Profit

2,335.0

2,501.0

2,231.0

3,225.0

3,145.0

2,937.0

Selling General & Admin Expenses, Total

849.0

907.0

1,014.0

1,567.0

1,570.0

1,610.0

R&D Expenses

568.0

575.0

609.0

935.0

1,223.0

1,248.0

Amortization of Goodwill and Intangible Assets

35.0

34.0

28.0

71.0

173.0

191.0

Other Operating Expenses, Total

1,452.0

1,516.0

1,651.0

2,573.0

2,966.0

3,049.0

Operating Income

883.0

985.0

580.0

652.0

179.0

-112.0

Interest Expense, Total

-57.0

-52.0

-49.0

-61.0

-26.0

-68.0

Interest And Investment Income

44.0

75.0

41.0

11.0

54.0

Net Interest Expenses

-13.0

23.0

-8.0

-61.0

-15.0

-14.0

Currency Exchange Gains (Loss)

Other Non Operating Income (Expenses)

3.0

-5.0

11.0

9.0

-13.0

-3.0

EBT, Excl. Unusual Items

873.0

1,003.0

583.0

600.0

151.0

-129.0

Restructuring Charges

-30.0

-121.0

Merger & Related Restructuring Charges

-25.0

-745.0

Impairment of Goodwill

-3,914.0

-821.0

Gain (Loss) On Sale Of Investments

21.0

62.0

291.0

917.0

-122.0

-78.0

Gain (Loss) On Sale Of Assets

54.0

Asset Writedown

Legal Settlements

-619.0

-35.0

Other Unusual Items

-1.0

7.0

112.0

198.0

66.0

EBT, Incl. Unusual Items

894.0

1,118.0

856.0

884.0

-4,336.0

-1,118.0

Income Tax Expense

112.0

128.0

200.0

122.0

68.0

7.0

Earnings From Continuing Operations

782.0

990.0

656.0

762.0

-4,404.0

-1,125.0

Minority Interest

44.0

12.0

Net Income

826.0

1,002.0

656.0

762.0

-4,404.0

-1,125.0

Preferred Dividend and Other Adjustments

Net Income to Common Incl Extra Items

826.0

1,002.0

656.0

762.0

-4,404.0

-1,125.0

Net Income to Common Excl. Extra Items

826.0

1,002.0

656.0

762.0

-4,404.0

-1,125.0

Total Shares Outstanding

147.0

147.0

146.0

157.0

158.0

158.0

Weighted Avg. Shares Outstanding

147.0

147.0

147.0

150.0

157.0

157.8

Weighted Avg. Shares Outstanding Dil

149.0

149.0

148.0

151.0

157.0

157.8

EPS

5.6

6.8

4.5

5.1

-28.1

-7.1

EPS Diluted

5.6

6.7

4.5

5.0

-28.1

-7.1

EBITDA

1,062.0

1,173.0

767.0

903.0

573.0

317.0